Michael Wood | Investor Relations, LifeSci Advisors |
Dror Harats | Chief Executive Officer |
Amos Ron | Chief Financial Officer |
Jonathan Aschoff | ROTH Capital Partners |
Ram Swayampakula | H.C. Wainwright |
Sam Slutsky | LifSci Capital |
Jonathan Kreizman | Valore Research |
Thank you all for participating today's First Quarter 2020 Results and Corporate Update Call for VBL Therapeutics. Leading the call today will be Prof. Dror Harats, CEO; and Amos Ron, the Company’s CFO. A press release with the company’s financial results became available at 7 O’clock Eastern Time today and can be found on the Investors page of the company’s website.
Before we begin, I’d like to remind everyone that various remarks about future expectations, plans and prospects constitute forward-looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995.